IMI AMR ACCELERATOR

amr-accelerator.bsky.social

19 December 2025 14:41

In this latest study under @era4tb.bsky.social, researchers adopted physiologically‑based pharmacokinetic (PBPK) modelling and used a detailed computational model to project what those concentrations likely are in human lungs (both healthy and TB-infected). 👉 Read at: https://bit.ly/3KA2RQx

IMI AMR ACCELERATOR

amr-accelerator.bsky.social

16 October 2025 11:55

Our latest research under @era4tb.bsky.social, highlights that small adjustments in the hollow fiber assays better reflects how TB drugs really perform. Learn more through a webinar on 21 October 2025. 👉 Research paper: https://bit.ly/4q7jIKE 👉 Webinar registration: https://bit.ly/3VN3Sa5

Innovative Health Initiative

ihieurope.bsky.social

02 October 2025 11:14

⏰ Tick tock, the clock is ticking! Just ONE WEEK to go until the deadline for call 11! If you have an idea and a consortium that can address one of these 5 topics, then make sure you get your proposal in on time by 9 October 2025. #IHITransformingHealth #EUResearch #EUFunding #HorizonEurope

IMI AMR ACCELERATOR

amr-accelerator.bsky.social

23 September 2025 10:05

Collaboration in AMR R&D is multisectoral, but not every question moves a project forward. Early scientific advice from EMA is key to understanding what to ask (and not to). 🎥 Watch the complete webinar at: https://bit.ly/4mpXPTx

IMI AMR ACCELERATOR

amr-accelerator.bsky.social

12 September 2025 08:21

@era4tb.bsky.social researchers found compounds that block TB’s ESX-1 system (used to damage immune cells) while also improving effectiveness of ethionamide. A dual-action step against drug-resistant TB. 👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw